22nd Century Profit Margin 2012-2025 | XXII
Current and historical gross margin, operating margin and net profit margin for 22nd Century (XXII) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. 22nd Century net profit margin as of December 31, 2025 is -37.64%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Consumer Staples | Tobacco Products | $0.003B | $0.024B |
| 22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Philip Morris (PM) | United States | $291.893B | 24.87 |
| British American Tobacco (BTI) | United Kingdom | $121.628B | 0.00 |
| Altria (MO) | United States | $112.891B | 12.41 |
| JAPAN TOB (JAPAY) | Japan | $70.917B | 21.94 |
| Imperial Tobacco Group (IMBBY) | United Kingdom | $35.552B | 0.00 |
| Turning Point Brands (TPB) | United States | $2.513B | 40.67 |
| Universal (UVV) | United States | $1.332B | 13.74 |
| Ispire Technology (ISPR) | United States | $0.185B | 0.00 |
| Charlie's Holdings (CHUC) | United States | $0.070B | 26.00 |